Log in

NASDAQ:EDAPEdap Tms Stock Price, Forecast & News

$3.31
+0.16 (+5.08 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.25
Now: $3.31
$3.47
50-Day Range
$2.36
MA: $2.92
$3.43
52-Week Range
$1.46
Now: $3.31
$5.39
Volume40,466 shs
Average Volume113,619 shs
Market Capitalization$95.98 million
P/E Ratio47.29
Dividend YieldN/A
Beta1.68
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells consumables; and offers treatment related services and maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is headquartered in Vaulx-en-Velin, France.
Read More
Edap Tms logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EDAP
CUSIPN/A
Phone33-04-72-15-31-50

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$50.23 million
Cash Flow$0.13 per share
Book Value$1.06 per share

Profitability

Net Income$1.69 million

Miscellaneous

Employees215
Market Cap$95.98 million
Next Earnings Date8/26/2020 (Estimated)
OptionableOptionable
$3.31
+0.16 (+5.08 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EDAP News and Ratings via Email

Sign-up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Edap Tms (NASDAQ:EDAP) Frequently Asked Questions

How has Edap Tms' stock been impacted by Coronavirus (COVID-19)?

Edap Tms' stock was trading at $2.48 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EDAP stock has increased by 33.5% and is now trading at $3.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Edap Tms?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Edap Tms
.

When is Edap Tms' next earnings date?

Edap Tms is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020.
View our earnings forecast for Edap Tms
.

How were Edap Tms' earnings last quarter?

Edap Tms SA (NASDAQ:EDAP) announced its quarterly earnings results on Monday, March, 30th. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.06 by $0.09. The medical equipment provider earned $13.35 million during the quarter, compared to analyst estimates of $14.27 million. Edap Tms had a net margin of 4.38% and a return on equity of 20.15%.
View Edap Tms' earnings history
.

What price target have analysts set for EDAP?

2 equities research analysts have issued 1 year price targets for Edap Tms' stock. Their forecasts range from $5.00 to $5.50. On average, they anticipate Edap Tms' stock price to reach $5.25 in the next twelve months. This suggests a possible upside of 58.6% from the stock's current price.
View analysts' price targets for Edap Tms
.

Has Edap Tms been receiving favorable news coverage?

News articles about EDAP stock have been trending negative on Saturday, InfoTrie reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Edap Tms earned a coverage optimism score of -2.7 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Edap Tms
.

Are investors shorting Edap Tms?

Edap Tms saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 36,900 shares, a decline of 26.8% from the June 15th total of 50,400 shares. Based on an average daily volume of 92,900 shares, the short-interest ratio is presently 0.4 days.
View Edap Tms' Short Interest
.

Who are some of Edap Tms' key competitors?

What other stocks do shareholders of Edap Tms own?

Who are Edap Tms' key executives?

Edap Tms' management team includes the following people:
  • Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)
  • Mr. Franois Dietsch, Chief Financial Officer (Age 43)
  • Ms. Blandine Confort, Investor Relations Officer and Sec.

What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by a variety of institutional and retail investors. Top institutional investors include Opaleye Management Inc. (6.48%), Accredited Investors Inc. (0.46%), Commonwealth Equity Services LLC (0.17%) and Envestnet Asset Management Inc. (0.05%).

Which institutional investors are selling Edap Tms stock?

EDAP stock was sold by a variety of institutional investors in the last quarter, including Opaleye Management Inc., and Accredited Investors Inc..

Which institutional investors are buying Edap Tms stock?

EDAP stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., and Commonwealth Equity Services LLC.

How do I buy shares of Edap Tms?

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $3.31.

How big of a company is Edap Tms?

Edap Tms has a market capitalization of $95.98 million and generates $50.23 million in revenue each year. The medical equipment provider earns $1.69 million in net income (profit) each year or $0.06 on an earnings per share basis. Edap Tms employs 215 workers across the globe.

What is Edap Tms' official website?

The official website for Edap Tms is www.edap-tms.com.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.